Silk Therapeutics, Inc., headquartered in Boston, MA, is the leader in silk protein solutions for human health and wellness. The founders of Silk Therapeutics are world-renowned as pioneers in silk science to improve human health. Dr. Greg Altman, CEO, and Dr. Rebecca Horan, Chief Operating Officer, have worked together for more than 15 years developing silk-based applications used in a number of medical products, and are currently focused on addressing unmet needs in the treatment and enhancement of skin. Dr. Horan's personal experience as a cancer survivor, and the company's commitment to the wellbeing of its customers, is the foundation for Silk Therapeutics pure, risk-free skincare that work naturally with the body.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/26/15 | $2,000,000 | Series A-1 |
Kraft Group | undisclosed |
| 02/03/16 | $6,000,000 | Series A-2 |
Erin Donohue Highland Capital Partners Lear Corporation Richard Sackler Roy P. Disney The Kraft Group | undisclosed |
| 09/28/17 | $11,000,000 | Series A-3 |
Altman Health Investments Jeff Vinik  Lear Corporation Roy P. Disney The Kraft Group | undisclosed |
